Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 8Glioblastoma 4Meningioma 3Delirium 2Central Nervous System Diseases 2Breast Neoplasms 2Water-Electrolyte Imbalance 1Spinal Cord Neoplasms 1Seizures 1Radiation Injuries 1Neuroinflammatory Diseases 1Neurocognitive Disorders 1Melanoma 1Lung Neoplasms 1Hypoxia 1Hemorrhage 1Gliosarcoma 1Glioma 1Gastrointestinal Neoplasms 1Gangliosidosis, GM1 1Gangliosidoses 1Colorectal Neoplasms 1Cognitive Dysfunction 1Acid-Base Imbalance 1

Interventions

Temozolomide 3gadobenic acid 2XENP 1595 2Trastuzumab 2Sodium Chloride 2Dexmedetomidine 2Cancer Vaccines 2Adjuvants, Immunologic 2veliparib 1tucatinib 1tipifarnib 1sagopilone 1pembrolizumab 1interferon gamma-1b 1glutathione pegylated liposomal doxorubicin 1gadoteridol 1elacestrant 1abemaciclib 1Tissue Banks 1Saline Solution 1Rituximab 1Radiotherapy 1Radiation 1RAD1901 1Oncolytic Virotherapy 1Interferon-gamma 1Immunotherapy 1Dasatinib 1Craniotomy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Central Nervous System Diseases × Sodium Chloride × CNS × Clear all
NCT04399343 2021-01-28

DEPOD

Capital Medical University

Phase 4 Unknown
700 enrolled
CNS

Central Nervous System Diseases, Delirium

NCT04494828 2021-01-12

Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor

Capital Medical University

Phase 4 Completed
60 enrolled
CNS

Central Nervous System Diseases, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡